Flash FinanceUS
Market open S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · NRX Pharmaceuticals, Inc. (NRXP)

NRx Pharmaceuticals sets Dec. 17, 2026 annual meeting and Oct. 28 record date

Neutral Impact 2 of 5 shareholder Written later

NRx Pharmaceuticals set December 17, 2026 as the date for its 2026 annual meeting of stockholders, which will be virtual-only, and October 28, 2026 as the record date for voting. The filing also sets revised deadlines for stockholder proposals and director nominations, which shareholders who want to act at the meeting need to meet.

Key points

  • 2026 Annual Meeting: December 17, 2026, 10:00 a.m. Eastern Time, virtual-only by live webcast
  • Record date for stockholders entitled to vote: October 28, 2026
  • Rule 14a-8 proposal and advance notice deadline: close of business October 25, 2026
  • Universal proxy notice deadline under Rule 14a-19: October 26, 2026

The filing

CompanyNRX Pharmaceuticals, Inc. (NRXP)
Form8-K, current report
Filed with the SECOct 16, 2026, 5:16 PM ET
Accession number0001437749-26-032828

Items reported: 8.01 Other Events

Read the filing on SEC.gov ↗

Written by AI on Nov 9, 2026, 8:53 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on October 16, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.